Early versus Late acute graft pyelonephritis: A retrospective analysis of graft and patient outcomes

Transpl Immunol. 2022 Dec:75:101657. doi: 10.1016/j.trim.2022.101657. Epub 2022 Jul 3.

Abstract

Background: Acute graft pyelonephritis (AGPN) is thought to affect graft and patient survival among renal transplant recipients. The objective was to compare outcomes among early AGPN (< 6 months from transplant) versus late AGPN (> 6 months from transplant).

Methods: This retrospective study analyzed 150 patients with AGPN dividing them into early and late AGPN from 2008 to 2016. Predictors of graft loss and mortality were compared using logistic regression analysis. Graft survival and patient survival were analyzed using Kaplan-Meyer survival plots.

Results: 55.3% (n = 83) had early AGPN and 44.7% (n = 67) had late AGPN. In early AGPN group, 13.3% had CMV disease on follow up compared to 3% in late AGPN group (p < 0.05). 26.5% had history of prolonged Foley's catheterization (> 5 days), 38.6% had prolonged DJ stent in-situ (> 2 weeks) following transplant surgery in the early AGPN compared to 7.5% and 19.4% respectively in the late AGPN group (p < 0.05). Recurrent GPN was more common in the late AGPN group - (35.8% versus 18.1%). Presence of renal abscess was predictive of graft loss in Univariate analysis (HR-6.12, p < 0.004). There was decreased death censored graft survival in the early AGPN group (p-0.035) with no significant difference in patient survival among the two groups.

Conclusion: Occurrence of early AGPN had a significant impact on long term graft survival in renal transplant recipients with no significant effect on patient survival. This study underlines the paramount importance of the prevention of UTIs in renal transplant recipients.

Keywords: Early; Late Graft pyelonephritis; graft outcome; patient survival; rejections; renal transplant.

MeSH terms

  • Graft Rejection / prevention & control
  • Graft Survival
  • Humans
  • Kidney Transplantation*
  • Pyelonephritis* / epidemiology
  • Retrospective Studies
  • Risk Factors
  • Treatment Outcome
  • Urinary Tract Infections* / epidemiology